PMID: 9423812Jan 10, 1998Paper

Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty cases

American Journal of Hematology
D PrzepiorkaCarlos Bueso-Ramos

Abstract

The role of allogeneic marrow transplantation as treatment of myeloproliferative disorders other than chronic myelogenous leukemia is not yet determined. At our center, 1 patient with primary myelofibrosis, 1 with mastocytosis, and 4 with myeloid metaplasia have been transplanted using HLA-identical sibling donors. All patients engrafted with full donor chimerism, and morphologic and cytogenetic manifestations of disease in the marrow resolved posttransplant. Three patients died; two with relapse and one from infection. The other three patients are alive in remission at 24+, 28+, and 32+ months posttransplant. Including these cases, a total of 40 patients transplanted for myeloproliferative disorders have been reported. The most common indications for transplantation were cytopenias, increasing blasts in marrow or blood, uncontrolled counts on conventional therapy, poor prognosis cytogenetics, organ dysfunction, and consolidation after induction therapy for blast transformation. Using the outcome data published for these patients, the actuarial estimate of 3-year survival is 55% (95% C.I., 44-76%) with a median reported follow-up of survivors of 21 months (range, 4-158 months). For patients with myeloproliferative disorders and...Continue Reading

References

Aug 1, 1992·British Journal of Haematology·N SchmitzR Sonnen
Dec 1, 1992·British Journal of Haematology·G J CreemersA Hagenbeek
Dec 1, 1989·British Journal of Haematology·N IfrahM Boasson
Jan 1, 1989·British Journal of Haematology·I DokalJ M Goldman
Nov 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M R O'DonnellA D Stock
Mar 13, 1982·Lancet·C RozmanR Brugués
Nov 15, 1981·Cancer·J W SmithC D Buckner
May 1, 1995·British Journal of Haematology·T FukushimaM Tomonaga
Jul 1, 1995·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·T N SagerA J Hansen
Jul 1, 1995·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·R B BanatiG W Kreutzberg
Sep 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S A GiraltI Khouri
Feb 1, 1996·American Journal of Hematology·F J Esteva-LorenzoA Mazumder
May 1, 1996·Journal of Pediatric Hematology/oncology·H C RossbachJ L Barbosa

❮ Previous
Next ❯

Citations

Aug 8, 2008·Blood·Dean D Metcalfe
Jan 11, 2008·Leukemia·N Kröger, R A Mesa
Oct 3, 2006·Bone Marrow Transplantation·S G PapageorgiouP D Kottaridis
Jun 30, 2012·Archives of Pathology & Laboratory Medicine·Maggie M Stoecker, Endi Wang
Jan 30, 2004·Annual Review of Medicine·Cem Akin, Dean D Metcalfe
Aug 26, 2006·Immunology and Allergy Clinics of North America·Todd M WilsonJamie Robyn
Feb 21, 2006·Histopathology·A M W van MarionJ G van den Tweel
Jul 26, 2000·Hematology/oncology Clinics of North America·K Hartmann, D D Metcalfe
Jul 26, 2000·Hematology/oncology Clinics of North America·A S Worobec
Oct 17, 2003·Hematology/oncology Clinics of North America·Alan S Wayne, A J Barrett
May 4, 2004·Immunology and Allergy Clinics of North America·Knut Brockow
Jan 16, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ronald HoffmanDamiano Rondelli
May 2, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Celalettin UstunPeter Valent
Aug 27, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Celalettin UstunPeter Valent
May 26, 2006·Pediatric Blood & Cancer·Harald ReinhardNorbert Graf
Jun 6, 2007·Current Allergy and Asthma Reports·Susan I Hungness, Cem Akin
Feb 24, 2010·International Journal of Hematology·Alessandro Rambaldi
Feb 1, 2007·Current Hematologic Malignancy Reports·William J HoganAyalew Tefferi
Aug 16, 2003·Blood·H Joachim DeegFrederick R Appelbaum
Sep 5, 2006·The Oncologist·Cecilia Arana-YiSrdan Verstovsek
Jan 31, 2017·Annual Review of Pathology·Dean D Metcalfe, Yoseph A Mekori
Oct 21, 2004·American Journal of Hematology·Bryan HennessySrdan Verstovsek
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G Barosi
Nov 27, 2004·Cancer·Bryan T HennessySrdan Verstovsek
Aug 11, 2021·British Journal of Haematology·Melody C Carter, Dean D Metcalfe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.